Detalhe da pesquisa
1.
Lutetium [177Lu]-DOTA-TATE in gastroenteropancreatic-neuroendocrine tumours: rationale, design and baseline characteristics of the Italian prospective observational (REAL-LU) study.
Eur J Nucl Med Mol Imaging
; 2024 May 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38772998
2.
Lymphopenia in patients affected by SARS-CoV-2 infection is caused by margination of lymphocytes in large bowel: an [18F]FDG PET/CT study.
Eur J Nucl Med Mol Imaging
; 49(10): 3419-3429, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35486145
3.
Tailored Molecular Imaging of Pheochromocytoma and Paraganglioma: Which Tracer and When.
Neuroendocrinology
; 112(10): 927-940, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35051937
4.
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer?
Future Oncol
; 18(2): 193-204, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34882010
5.
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors.
Eur J Nucl Med Mol Imaging
; 48(10): 3260-3267, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33604690
6.
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study.
Eur J Nucl Med Mol Imaging
; 48(9): 2871-2882, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33560453
7.
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance?
Oncology
; 98(10): 714-718, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32516768
8.
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice.
Eur J Nucl Med Mol Imaging
; 47(10): 2358-2371, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32062681
9.
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study.
Eur J Nucl Med Mol Imaging
; 47(10): 2372-2382, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32123969
10.
Multicentric breast cancer with heterogeneous histopathology: a multidisciplinary review.
Future Oncol
; 16(8): 395-412, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-32026709
11.
Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning.
Eur J Nucl Med Mol Imaging
; 45(13): 2426-2441, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29785514
12.
Role of interim 18F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic review.
Eur J Nucl Med Mol Imaging
; 44(11): 1915-1927, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28681192
13.
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE.
Eur J Nucl Med Mol Imaging
; 44(3): 490-499, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-27704193
14.
Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases.
Ann Surg Oncol
; 23(Suppl 5): 981-989, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27613553
15.
Long-term results of PRRT in advanced bronchopulmonary carcinoid.
Eur J Nucl Med Mol Imaging
; 43(3): 441-52, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26392198
16.
Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PET.
Eur J Nucl Med Mol Imaging
; 43(6): 1040-6, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26611427
17.
Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma.
Eur Radiol
; 26(12): 4432-4441, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26965504
18.
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors.
Eur J Nucl Med Mol Imaging
; 42(1): 5-19, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25273832
19.
Efficacy of 9°Yttrium-ibritumomab tiuxetan in relapsed/refractory extranodal marginal-zone lymphoma.
Hematol Oncol
; 32(1): 10-5, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23696416
20.
A PET-Surrogate Signature for the Interrogation of the Metabolic Status of Breast Cancers.
Adv Sci (Weinh)
; : e2308255, 2024 May 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38757578